BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $1.85 and last traded at $1.75, with a volume of 14381 shares traded. The stock had previously closed at $1.80.
BioRestorative Therapies Stock Down 2.8 %
The company’s 50-day moving average price is $1.59 and its 200-day moving average price is $1.51. The firm has a market cap of $2.87 billion, a price-to-earnings ratio of -1.68 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- ETF Screener: Uses and Step-by-Step Guide
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Roth IRA Calculator: Calculate Your Potential Returns
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
